Texas Capital initiated coverage of Globe Life (GL) with a Buy rating and $170 price target calling its valuation “attractive” given its growing life and health distribution franchise.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GL:
- Globe Life’s Growing Alternative Asset Bets Raise Volatility, Capital Strain and Liquidity Risk
- Globe Life price target raised to $171 from $170 at Wells Fargo
- Globe Life price target raised to $157 from $155 at Evercore ISI
- Globe Life Earnings Call Highlights Resilient Growth
- Globe Life price target raised to $181 from $180 at JPMorgan